Skip to content

Danaher Corporation (DHR) — insider trading

Health Care · NYSE

Danaher Corporation (DHR) has 55 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 55 (latest 2026-08-21).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-08-21 Blair Rainer Director, Officer (President & CEO) Open-market sale 7,755 $219.35 $1.70M Form 4
2026-08-21 Blair Rainer Director, Officer (President & CEO) Open-market sale 39,193 $218.73 $8.57M Form 4
2026-08-21 Blair Rainer Director, Officer (President & CEO) Open-market sale 11,307 $217.77 $2.46M Form 4
2026-08-04 RALES STEVEN M Director, Officer (Chairman) Grant / award / vesting (derivative) 1,000,000 — $0 Form 4
2026-08-04 RALES STEVEN M Director, Officer (Chairman) Grant / award / vesting 500,000 — $0 Form 4
2026-08-04 RALES MITCHELL P Director, Officer (Chairman of Exec. Committee) Grant / award / vesting (derivative) 1,000,000 — $0 Form 4
2026-08-04 RALES MITCHELL P Director, Officer (Chairman of Exec. Committee) Grant / award / vesting 500,000 — $0 Form 4
2026-08-04 Bouda Christopher Officer (VP, Chief Accounting Officer) Grant / award / vesting (derivative) 12,286 — $0 Form 4
2026-08-04 Sawyer Montgomery Julie A Officer (Executive Vice President) Grant / award / vesting (derivative) 245,701 — $0 Form 4
2026-08-04 Leiken Jonathan Officer (SVP-Chief Legal Officer) Grant / award / vesting (derivative) 92,138 — $0 Form 4
2026-08-04 Milosevich Gregory M Officer (Executive Vice President) Grant / award / vesting 15,402 — $0 Form 4
2026-08-04 Gutierrez-Ramos Jose-Carlos Officer (SVP, Chief Science Officer) Grant / award / vesting 13,477 — $0 Form 4
2026-08-04 Gugino Matthew E Officer (EVP & Chief Financial Officer) Grant / award / vesting (derivative) 153,563 — $0 Form 4
2026-08-04 Riley Christopher Paul Officer (Executive Vice President) Grant / award / vesting 41,072 — $0 Form 4
2026-07-31 Stevens Raymond C Director Grant / award / vesting (derivative) 182 $194.98 $35.4K Form 4
2026-07-31 Dewan Feroz Director Grant / award / vesting (derivative) 171 $194.98 $33.4K Form 4
2026-07-31 Sanders A Shane Director Grant / award / vesting (derivative) 211 $194.98 $41.2K Form 4
2026-07-31 List Teri Director Grant / award / vesting (derivative) 16 $194.98 $3.1K Form 4
2026-07-31 SPOON ALAN G Director Grant / award / vesting (derivative) 230 $194.98 $44.8K Form 4
2026-07-31 Zerhouni Elias A. Director Grant / award / vesting (derivative) 237 $194.98 $46.1K Form 4
2026-07-31 FILLER LINDA Director Grant / award / vesting (derivative) 18 $194.98 $3.6K Form 4
2026-07-15 Zerhouni Elias A. Director Option exercise / conversion (derivative) 3,298 — $0 Form 4
2026-07-15 Zerhouni Elias A. Director Shares withheld for taxes / exercise cost 1,181 $200.79 $237.1K Form 4
2026-07-15 Zerhouni Elias A. Director Option exercise / conversion 3,298 $71.88 $237.1K Form 4
2026-07-15 FILLER LINDA Director Option exercise / conversion (derivative) 3,298 — $0 Form 4
2026-07-15 FILLER LINDA Director Shares withheld for taxes / exercise cost 1,181 $200.79 $237.1K Form 4
2026-07-15 FILLER LINDA Director Option exercise / conversion 3,298 $71.88 $237.1K Form 4
2026-07-15 Bouda Christopher Officer (VP, Chief Accounting Officer) Shares withheld for taxes / exercise cost 60 $200.79 $12.0K Form 4
2026-05-15 Lamanna Charles W Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 Lamanna Charles W Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 Dewan Feroz Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 Dewan Feroz Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 Zerhouni Elias A. Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 Zerhouni Elias A. Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 List Teri Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 List Teri Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 Sanders A Shane Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 Sanders A Shane Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 SPOON ALAN G Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 SPOON ALAN G Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 Stevens Raymond C Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 Stevens Raymond C Director Grant / award / vesting 680 — $0 Form 4
2026-05-15 Couchara Georgeann Officer (SVP, Human Resources) Shares withheld for taxes / exercise cost 281 $161.91 $45.5K Form 4
2026-05-15 FILLER LINDA Director Grant / award / vesting (derivative) 1,699 — $0 Form 4
2026-05-15 FILLER LINDA Director Grant / award / vesting 680 — $0 Form 4
2026-05-01 SPOON ALAN G Director Option exercise / conversion (derivative) 3,298 — $0 Form 4
2026-05-01 SPOON ALAN G Director Open-market sale 1,358 $174.67 $237.2K Form 4
2026-05-01 SPOON ALAN G Director Option exercise / conversion 3,298 $71.88 $237.1K Form 4
2026-04-24 Dewan Feroz Director Grant / award / vesting (derivative) 188 $177.25 $33.3K Form 4
2026-04-24 SPOON ALAN G Director Grant / award / vesting (derivative) 252 $177.25 $44.7K Form 4
2026-04-24 FILLER LINDA Director Grant / award / vesting (derivative) 20 $177.25 $3.6K Form 4
2026-04-24 Zerhouni Elias A. Director Grant / award / vesting (derivative) 260 $177.25 $46.0K Form 4
2026-04-24 List Teri Director Grant / award / vesting (derivative) 17 $177.25 $3.1K Form 4
2026-04-24 Sanders A Shane Director Grant / award / vesting (derivative) 232 $177.25 $41.1K Form 4
2026-04-24 Stevens Raymond C Director Grant / award / vesting (derivative) 199 $177.25 $35.3K Form 4

Ask the chat about DHR's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Danaher Corporation (DHR).

Last updated 2026-08-21 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.